Omada Health President Sold Company Shares

President Wei-Li Shao sold 9,418 shares of Omada Health on August 12, 2026, as part of a pre-established trading plan.

Updated on Sept. 23, 2026 in Healthcare

Bold flat-color editorial illustration showing balanced navy and cream metal geometric plates, symbolizing structured corporate financial policy.
Omada Health President Wei-Li Shao sold 9,418 shares of company stock on August 12, 2026, as part of a pre-established trading plan. AI Illustration. Upload story photo >

Live Poll

Do you consider executive stock sales as a sign of declining confidence in a company?

Omada Health President Wei-Li Shao offloaded 9,418 shares of the company on August 12, 2026. The transaction, which generated approximately $236,000, was executed under a Rule 10b5-1 trading plan.

Why it matters

Executive stock sales carried out through Rule 10b5-1 trading plans are standard procedures that allow corporate officers to divest assets while adhering to regulations that prevent insider trading.

The transaction was completed at a weighted average price of $25.02 per share. Following the sale, Shao maintains 307,372 shares in the company, which currently holds a market capitalization of $1.3 billion.

The players

Wei-Li Shao

He serves as the president of the digital health company Omada Health.

Omada Health

This is a digital healthcare company that provides behavior change programs for chronic disease prevention and management.

The details

The divestment was conducted pursuant to a trading plan adopted on March 13, 2026, to ensure compliance with securities laws. Omada Health, which employs 946 people, reported trailing-twelve-month revenue of $309.8 million and a net income of $4.3 million.

Timeline

  1. March 13, 2026: Wei-Li Shao adopted a Rule 10b5-1 trading plan.

  2. August 12, 2026: The president sold 9,418 company shares.

  3. September 23, 2026: The sale was reported in an SEC Form 4 filing.

Market Landscape

The use of Rule 10b5-1 to automate stock sales follows a pattern of corporate governance designed to mitigate accusations of insider trading. This practice allows executives at major firms to signal commitment to their long-term equity positions while maintaining transparency with shareholders.

This transaction has no direct impact on the day-to-day services or subscription costs for Omada Health patients. The move represents a personal financial realignment by the company's leadership rather than a change in the firm's operational strategy.

The takeaway

Executives typically utilize automated trading plans to provide transparency and avoid the appearance of trading on non-public information. Shareholders generally monitor these filings to understand insider confidence and personal portfolio management at the firm.

Further reading

For more on the industry's financial movements, see Healthcare.

Live Poll

Do you consider executive stock sales as a sign of declining confidence in a company?